Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New Studies Focus On Lignans and Breast Health
Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women.
- New Studies Focus On Lignans and Breast Health
Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women.
- New Studies Focus On Lignans and Breast Health
Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women.
- New Studies Focus On Lignans and Breast Health
Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women.
- Meta-Analysis Confirms Venaforce Horse Chestnut Extract To Be Effective for CVI
Study appeared in the journal, Advances in Therapy, Jan/Feb, 2006 - shown in meta-analysis of five studies to be effective in reducing the symptoms associated with chronic venous insufficiency, such as lower leg swelling.
- Meta-Analysis Confirms Venaforce Horse Chestnut Extract To Be Effective for CVI
Study appeared in the journal, Advances in Therapy, Jan/Feb, 2006 - shown in meta-analysis of five studies to be effective in reducing the symptoms associated with chronic venous insufficiency, such as lower leg swelling.
- Plants Help Fight Cardiovascular Disorders
On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition.
- Plants Help Fight Cardiovascular Disorders
On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition.
- Plants Help Fight Cardiovascular Disorders
On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition.
- Plants Help Fight Cardiovascular Disorders
On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition.
- Plants Help Fight Cardiovascular Disorders
On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes
Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes.
- New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes
Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes.
- New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes
Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes.
- Study: Soy Germ Isoflavones Reduce Bone Loss
A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones.
- Study: Soy Germ Isoflavones Reduce Bone Loss
A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones.
- Study: Soy Germ Isoflavones Reduce Bone Loss
A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones.
- Study: Soy Germ Isoflavones Reduce Bone Loss
A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones.
- Study: Soy Germ Isoflavones Reduce Bone Loss
A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones.
- CRN Risk Assessments For Non-Essential Nutrients Published
The Council for Responsible Nutrition (CRN) has authored risk assessments, published by the peer-reviewed journal Regulatory Toxicology and Pharmacology, for coenzyme Q10 (CoQ10), carotenoids lutein and lycopene, and creatine monohydrate.
- CRN Risk Assessments For Non-Essential Nutrients Published
The Council for Responsible Nutrition (CRN) has authored risk assessments, published by the peer-reviewed journal Regulatory Toxicology and Pharmacology, for coenzyme Q10 (CoQ10), carotenoids lutein and lycopene, and creatine monohydrate.
- New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome
study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation.
- New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome
study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation.
- New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome
study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation.
- New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome
study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation.
- New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome
study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation.
- Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency
Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI.
- Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency
Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI.
- Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency
Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI.
- Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency
Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- New Studies Indicate That Tocomin® / Tocomin® SupraBio(TM) Supplementation Elevates Blood Levels Sufficiently to Protect Against Stroke-Induced Neurodegeneration
Two NIH-funded studies conducted at the Ohio State University Medical Center, published in the May, 2006 issue of the journal Antioxidant & Redox Signaling and June 26th issue of the Journal of Neurochemistry, demonstrate that taking tocotrienols (Tocomin® and Tocomin® SupraBioTM) orally is an effective way to elevate blood plasma levels to concentrations that could help protect against neurological damage resulting from stroke
- New Studies Indicate That Tocomin® / Tocomin® SupraBio(TM) Supplementation Elevates Blood Levels Sufficiently to Protect Against Stroke-Induced Neurodegeneration
Two NIH-funded studies conducted at the Ohio State University Medical Center, published in the May, 2006 issue of the journal Antioxidant & Redox Signaling and June 26th issue of the Journal of Neurochemistry, demonstrate that taking tocotrienols (Tocomin® and Tocomin® SupraBioTM) orally is an effective way to elevate blood plasma levels to concentrations that could help protect against neurological damage resulting from stroke
- New Studies Indicate That Tocomin® / Tocomin® SupraBio(TM) Supplementation Elevates Blood Levels Sufficiently to Protect Against Stroke-Induced Neurodegeneration
Two NIH-funded studies conducted at the Ohio State University Medical Center, published in the May, 2006 issue of the journal Antioxidant & Redox Signaling and June 26th issue of the Journal of Neurochemistry, demonstrate that taking tocotrienols (Tocomin® and Tocomin® SupraBioTM) orally is an effective way to elevate blood plasma levels to concentrations that could help protect against neurological damage resulting from stroke
- Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil
Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial.
- Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil
Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial.
- Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil
Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial.
- Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil
Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial.
- Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil
Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial.
- Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil
Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial.
- Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil
Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Research Suggests That Diosmin Can Help Improve Diabetic Vascular Conditions
French research on Daflon 500 mg taken daily (90% of which is comprised of the supplement Diosmin), indicates 12 of 13 patients in one study showed normalization of albumin levels in the urine after treatment, second study (placebo controlled, 20 patients in each group) indicated that in 65% of supplementation group, albumin levels normalized, compared to only 25% of patients in the placebo group.
- Research Suggests That Diosmin Can Help Improve Diabetic Vascular Conditions
French research on Daflon 500 mg taken daily (90% of which is comprised of the supplement Diosmin), indicates 12 of 13 patients in one study showed normalization of albumin levels in the urine after treatment, second study (placebo controlled, 20 patients in each group) indicated that in 65% of supplementation group, albumin levels normalized, compared to only 25% of patients in the placebo group.
- Research Suggests That Diosmin Can Help Improve Diabetic Vascular Conditions
French research on Daflon 500 mg taken daily (90% of which is comprised of the supplement Diosmin), indicates 12 of 13 patients in one study showed normalization of albumin levels in the urine after treatment, second study (placebo controlled, 20 patients in each group) indicated that in 65% of supplementation group, albumin levels normalized, compared to only 25% of patients in the placebo group.
- Research Suggests That Diosmin Can Help Improve Diabetic Vascular Conditions
French research on Daflon 500 mg taken daily (90% of which is comprised of the supplement Diosmin), indicates 12 of 13 patients in one study showed normalization of albumin levels in the urine after treatment, second study (placebo controlled, 20 patients in each group) indicated that in 65% of supplementation group, albumin levels normalized, compared to only 25% of patients in the placebo group.
- Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise
Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise.
- Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise
Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise.
- Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise
Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise.
- Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise
Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise.
- Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise
Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise.
- Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise
Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise.
- Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise
Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Green Bay, WI (July 13, 2006) – EuroPharma’s president, Terry Lemerond, recently obtained the North America distribution rights to a revolutionary Omega -3 phospholipid complex with DHA/EPA, called Vectomega®. Molecularly different from other omega-3’s on the market, this new complex is 50 times more absorbable across cellular membranes than other DHA/EPA products and is available as a water/oil soluble powder.
Now, preliminary findings from a recent human trial by French doctors demonstrate that only 2 tablets per day of Vectomega® improve cardiovascular health by reducing cholesterol, triglycerides and increasing HDL-c in a healthy population, among other benefits.
The extensive criteria studied make it possible to envision a wide range of health concerns in which Vectomega®’s phospholipids can be of benefit. In addition to cardiovascular support, it also shows positive activity in the area of cellular aging, memory, sleep quality, physical recovery, and many other areas of anti-aging. Clinical tolerance in this trial was excellent; no side effects were reported; specifically no eructation, and no reflux of fish taste. The study population was forty healthy volunteers followed for 60 days, and compliance was 100%. Dosage was one 300 mg tablet two times daily. Food habits were not modified.
Omega 3 fish oils used for its DHA/EPA have become increasingly popular in response to a growing body of science on its health benefits, yet few products have risen above the pack. Vectomega®’s superior bioavailability, rapidly noticed results, and the novel dosage form are about to change that.
Vectomega® is a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature. Vectomega® uses a biological innovation that extracts naturally occurring marine phospholipids with the omega-3 fatty acids, EPA and DHA. Standard fish oil products do not contain these marine phospholipids. This patented innovation, called vectorization, uses a gentle, cold water and enzyme process avoiding heat, solvents, and chemical modifications unlike the process utilized by standard fish oil products.
“The results from this latest trial support previous findings and prove that Vectomega® has optimal bioavailability and works on a cellular level. My decades of experience in the supplements industry tells me this is destined to hold a prime position in the fight against anti-aging and to support optimal health at all levels,” stated Terry Lemerond, president of EuroPharma. “Vectomega® surpasses other DHA/EPA products in terms of bioavailability, absorption and efficacy. Additionally, because it is a water and oil soluble powder, Vectomega® can be applied to any commercial food or dietary supplement formulation to dramatically increase its market potential.”
Vectomega®’s phospholipid vectorization has been clinically demonstrated to have superior bioavailability compared to standard fish oil products. In technical terms, the amphiphilic properties of the marine phospholipids can easily cross the hydrophilic membrane barriers for superior bioabsorption compared to “neutrally charged” commercial fish oils on the market today. Research has confirmed that 50 times more Vectomega® DHA and EPA crosses the cell membrane as compared to standard commercial fish oil products.
At the therapeutic dose, 2 tablets (600 mg) of Vectomega® are equal to 16 capsules (7,200 mg) of standard fish oil. Research has shown that because Vectomega®’s marine phospholipids are vectorized with DHA and EPA in a specific location on the carbon chain (Sn-2 on the glycerol), Vectomega® is 50 times more absorbable via cell membranes.
EuroPharma offers Vectomega® in raw material or finished tablet form, manufacturers seeking more information on availability and pricing should contact Lisa Joski at Ljoski@EuroPharmaUSA.com, 920-406-6500 or visit www.EuroPharmaUSA.com.
EuroPharma, Inc. a Green Bay, Wisconsin-based supplier offers Vectomega® and other truly unique and industry changing ingredients. EuroPharma’s president, Terry Lemerond has over 40 years of industry experience and product development expertise. Lemerond’s background, knowledge, and associations with respected doctors and scientists worldwide allow him continuous access to proven formulas and ingredients that have yet to be introduced to the world or to the U.S. market.
-- END –
Contact: Lisa Joski 920-406-6506
Ljoski@EuroPharmaUSA.com |